EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA

Ludy R Carmola, Allison Dorothy Roebling, Dara Khosravi, Rose M Langsjoen, Andrei Bombin iD, Bri Bixler, Alex Reid iD, Cara Chen, Ethan Wang, Yang Lu iD, Ziduo Zheng, Rebecca Zhang und 16 weitere

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0317972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Ludy R Carmola und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCEZID CDC HHS, NIAID NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While SARS-CoV-2 vaccines have shown strong efficacy, the continued emergence of new viral variants raises concerns about the ongoing and future public health impact of COVID-19, especially in locations with suboptimal vaccination uptake. We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. We analyzed clinical and demographic data from 1,957 individuals in the state of Georgia, USA, coupled with viral genome sequencing from 1,185 samples. We found no specific mutations associated with disease severity. Compared to those who were unvaccinated, vaccinated individuals experienced less severe SARS-CoV-2 disease, and the effect was similar for both variants. Vaccination within the prior 3-9 months was associated with decreased odds of moderate disease, severe disease, and death. Older age and underlying health conditions, especially immunosuppression and renal disease, were associated with increased disease severity. Overall, this study provides insights into the impact of vaccination status, variants/mutations, and clinical factors on disease severity in SARS-CoV-2 infection when vaccination rates are low. Understanding these associations will help refine and reinforce messaging around the crucial importance of vaccination in mitigating the severity of SARS-CoV-2 disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansGeorgiaMaleFemaleMiddle AgedAdultSeverity of Illness IndexAgedAdolescentVaccinationCOVID-19 VaccinesYoung AdultGenome, ViralChildMutationChild, PreschoolAged, 80 and over

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
  • Georgia Department of Health, Georgia Emerging Infections Program, Atlanta, Georgia, United States of America.
  • Atlanta Veterans Affairs Medical Center, Decatur, Georgia, United States of America.
  • Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America.
  • Graduate Program in Genetics and Molecular Biology, Emory University, Atlanta, Georgia, United States of America.
  • Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.

ORCID-Profile: Andrei Bombin, Alex Reid, Yang Lu, Robert A Arthur, Alaa Ahmed, John Hunter Crumpler, Ahmed Babiker, Anne Piantadosi

Förderung

  • NCEZID CDC HHS
  • NIAID NIH HHS
  • NCATS NIH HHS
  • NIBIB NIH HHS
  • NIEHS NIH HHS
  • CDC HHS
  • Centers for Disease Control and Prevention Foundation
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Carmola, L. R., Roebling, A. D., Khosravi, D., Langsjoen, R. M., Bombin, A., Bixler, B., Reid, A., Chen, C., Wang, E., Lu, Y., Zheng, Z., Zhang, R., Nguyen, P. V., Arthur, R. A., Fitts, E., Gulick, D. A., Higginbotham, D., Taz, A., Ahmed, A., …, & Piantadosi, A. (2025). Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA. PLOS ONE. https://doi.org/10.1371/journal.pone.0317972

Vancouver

Carmola LR, Roebling AD, Khosravi D, Langsjoen RM, Bombin A, Bixler B, et al. Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA. PLOS ONE. 2025. doi:10.1371/journal.pone.0317972

BibTeX
@article{Carmola2025,
  author = {Carmola, Ludy R and Roebling, Allison Dorothy and Khosravi, Dara and Langsjoen, Rose M and Bombin, Andrei and Bixler, Bri and Reid, Alex and Chen, Cara and Wang, Ethan and Lu, Yang and Zheng, Ziduo and Zhang, Rebecca and Nguyen, Phuong-Vi and Arthur, Robert A and Fitts, Eric and Gulick, Dalia Arafat and Higginbotham, Dustin and Taz, Azmain and Ahmed, Alaa and Crumpler, John Hunter and Kraft, Colleen and Lam, Wilbur A and Babiker, Ahmed and Waggoner, Jesse J and Openo, Kyle P and Johnson, Laura M and Westbrook, Adrianna and Piantadosi, Anne},
  title = {Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0317972}
}
Kostenlos starten →